Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors’ Target Prediction

<div>KEGG dot plot of the top 20 pathways enrichment of 169 putative pleiotropic genes and 21 potential pleiotropic therapeutic targets for SGLT2 inhibitors.</div>

BioMed Research International

fig6

Figure 6

Figure 6: Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors’ Target Prediction 

Figure 6 | Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors’ Target Prediction 